摘要
The convergence of nanotechnology,material science,biology and medicine promotes the rapid development of nano-biomedicine,which plays an important role in relieving the pain of patients and improving the health of human,in particular of cancer therapy.Construction of stimuli-responsive controlled release system for targeted drug delivery to specific cells is essentially important for cancer therapy since most chemotherapeutics are severely toxic<sup>[1]</sup>.During past decades,magnetic nanoparticles(MNPs)and mesoporous silica nanoparticles(MSNs)attracted much attention in the related field,due to their good biocompatibility。
The convergence of nanotechnology,material science,biology and medicine promotes the rapid development of nano-biomedicine,which plays an important role in relieving the pain of patients and improving the health of human,in particular of cancer therapy.Construction of stimuli-responsive controlled release system for targeted drug delivery to specific cells is essentially important for cancer therapy since most chemotherapeutics are severely toxic[1].During past decades,magnetic nanoparticles(MNPs)and mesoporous silica nanoparticles(MSNs)attracted much attention in the related field,due to their good biocompatibility,large
出处
《医用生物力学》
EI
CAS
CSCD
北大核心
2013年第S1期5-6,共2页
Journal of Medical Biomechanics
基金
financially supported by Natural Science Foundation of China(21274169 and 31200712)
Fundamental Research Funds for the Central Universities(Project No.CDJZR 10238801)
"111 project"(B06023)